Two minor components designated mycotrienols I and II which were concurrently produced with mycotrienins I and II by Streptomyces rishiriensis T-23 were isolated and characterized. Like mycotrienins I and II, mycotrienols I and II are also interconvertible via redox reaction and their structures have been established as depicted in 3 and 4 on the basis of 13C NMR evidence along with chemical degradation. The biological activities are discussed.
No takes yet. Share an insight, caveat, or question.
Sugita et al. (1982) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: